Pfizer Stock News

The U.S. health agency has recommended people get the Moderna or Pfizer COVID vaccines instead of J&J''s over concerns about rare blood clots.

Pfizer stock reversed a six-day running spree Friday after the company reported mixed test results for its Covid vaccine in young children.

Alexander Gintsburg, the director of the Gamaleya Research Institute of Epidemiology and Microbiology, said that the Sputnik V COVID-19 vaccine showed high efficiency against the Omicron variant, Sputnik reported on Friday. Gintsburg explained that the two-dose Russian vaccine can be effective more than the other vaccine brands such as Pfizer, and Moderna, saying: Sputnik V []

Mechanics Bank Trust Department cut its position in Pfizer Inc. (NYSE:PFE) by 2.5% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 166,010 shares of the biopharmaceutical companys stock after selling 4,232 shares during the quarter. Pfizer comprises 1.2% of Mechanics Bank []

Additional manufacturing site for COVID-19 vaccine Janssen EMAs human medicines committee (CHMP) has approved an additional manufacturing site for the production of COVID-19 Vaccine Janssen, developed by Janssen-Cilag International NV. The site, located in Marcy-lÉtoile, France, and operated by Sanofi Pasteur, will manufacture finished product. The site is expected to support the continued supply of []

American children under the age of 5 may not be vaccinated until mid-2022 as Pfizer said Friday that it''s going to now test a third dose of its Covid-19 vaccine in the trial. The decision comes as Pfizer announced that non-inferiority was not met for children between the ages of

COVID-19 vaccines produced by Johnson & Johnson and China''s Sinopharm, as well as the Russian-made Sputnik V, were found to provide little or no protection against the newly emerging Omicron variant, according to a study out this week. Driving the news: The study, which was published as a preprint and isn''t yet peer-reviewed, found that just three out of 13 people who were fully vaccinated with China''s Sinopharm vaccine produced neutralizing antibodies against Omicron. One out of 12 people with the Johnson & Johnson vaccine exhibited neutralizing antibodies. None of the 11 with Russia''s Sputnik V vaccine revealed protection, per the study conducted by researchers at the University of Washington and Swiss drugmaker Humabs Biomed SA. The study also found that the best protection against Omicron appears to come from both having a prior COVID-19 infection and two doses of a Pfizer vaccine. The big picture: The study comes as COVID cases are surging around the globe, appearing to be driven by the new variant.

Health agency bosses reported death threats before approving the Pfizer vaccine for young children. Bolsonaro says public should make "their own judgements" on the decisionmakers.

NEW YORK , Dec. 17, 2021 /PRNewswire/ -- The ongoing pandemic is causing renewed concerns as new variants are becoming more prominent. As an example, test positivity rates in New York City have doubled in just three days, Dr. Jay Varma , a top health advisor to Mayor Bill de Blasio , tweeted Thursday. According to data provided by the CDC on Wednesday, New York and New Jersey are the two states with the most rapid spread of the Omicron variant. To identify and track SARS-CoV-2 variants, CDC uses genomic surveillance. CDC''s national genomic surveillance system collects SARS-CoV-2 specimens for sequencing through the National SARS-CoV-2 Strain Surveillance (NS3) program, as well as SARS-CoV-2 sequences generated by commercial or academic laboratories contracted by CDC and state or local public health laboratories. In the meantime, restrictions for private businesses have become more strict. Todos Medical Ltd. (OTC: TOMDF ), Pfizer Inc. (NYSE: PFE ), Johnson & Johnson (NYSE: JNJ ), Inovio Pharmaceuticals, Inc. (NASDAQ: INO ), Vaxart, Inc. (NASDAQ: VXRT ) As a result of the most recent surge, schools like New York University and Cornell University have canceled in-person events and shifted finals online.

Modernas COVID-19 vaccine is up to four times more likely to cause inflammation of the heart muscle, a very rare side effect, than its rival vaccine from Pfizer-BioNTech , according to a Danish study published in the British Medical Journal late on Thursday. The study, in which almost 85% of

A 28-year-old woman has lost her life after she reportedly received Pfizer vaccine in Ruiru, Kiambu County. In a police report seen by K24 Digital, Rhoda Mwikali was accompanied by her husband John Matu Nderitu at a local hospital where they both got injected with the vaccine in a bid to prevent Covid-19. John however [] The post Woman dies in Ruiru after receiving COVID-19 vaccine appeared first on K24 TV .

In most Balkan countries, the situation with the spread of the coronavirus remains worrying. In some countries, the incidence is declining, but in others, the prevalence of coronavirus remains high. The new variant of COVID-19 Omicron, which has already been detected in seven countries - Turkey, Romania, Greece, Croatia, Slovenia, Montenegro, Cyprus - is of great concern. ALBANIA More than 300 new cases of COVID-19 have been registered in Albania in recent days. There are not many deaths in the country (several people a day). Since the beginning of the pandemic in Albania, nearly 205,000 cases of coronavirus infection have been registered and more than 3,150 people have died. To date, 2.22 million doses of COVID-19 vaccine have been administered in the country. 998 thousand people or 35 percent of the country''s population have been fully vaccinated. The vaccines of Pizer / Biontech, AstraZeneca, the Russian Sputnik V and the Chinese CoronaVac of the Sinovac company are allowed to be administered in Albania.

European Union governments have agreed to exercise an option to buy more than 180 million doses of a version of the COVID-19 vaccine adapted for the Omicron variant developed by BioNTech and Pfizer, the head of the European Commission said. Pfizer and BioNTech began development of a prototype Omicron-specific vaccine

People should not use the Johnson & Johnson (J&J) vaccine against Covid-19, with Pfizer / Biontech and Moderna vaccines available, the Centers for Disease Control and Prevention (CDC) said. CDC figures show that at least 54 people in the United States, most of them women, have been hospitalized for blood clots, and nine have died after being vaccinated with J&J. The recommendation to give preference to Pfizer and Moderna vaccines was made by CDC Director Dr. Rochelle Valensky after hearing members of the Advisory Committee of the Agency for Immunization Practices on the risk of rare but life-threatening blood clots associated with the Johnson & Johnson vaccine. The advisory committee met after the Food and Drug Administration announced that it had added a contraindication to the Johnson & Johnson vaccine for people who had previously developed thrombosis with thrombocytopenia after receiving one dose of the vaccine should not receive a second dose. The administration also said that the highest frequency of reporting a blood clot problem - about 1 case per 100,000 doses - was in women aged 30 to 49.